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E-mail address: Tamura.Teruko@MH-Hannover.deTHOC7 and Fms-interacting protein (FMIP) are members of the THO complex that associate with the
mRNA export apparatus. FMIP is a nucleocytoplasmic shuttling protein with a nuclear localization
signal (NLS), whereas THOC7 does not contain a typical NLS motif. We show here that THOC7 (50–
137, amino acid numbers) binds to the N-terminal portion (1–199) of FMIP directly. FMIP is detected
mainly in the nucleus. In the absence of exogenous FMIP, THOC7 resides mainly in the cytoplasm,
while in the presence of FMIP, THOC7 is transported into the nucleus with FMIP. Furthermore,
THOC7 lacking the FMIP binding site does not co-localize with FMIP, indicating that THOC7/FMIP
interaction is required for nuclear localization of THOC7.
Structured summary:
MINT-6799962, MINT-6799973, MINT-6800005: THOC7 (uniprotkb:Q6I9Y2) physically interacts
(MI:0218) with THOC5 (uniprotkb:Q13769) by pull down (MI:0096)
MINT-6800108: FMIP (uniprotkb:Q13769) and THOC7 (uniprotkb: Q6I9Y2) co-localize (MI:0403) by ﬂuo-
rescence microscopy (MI:0416)
MINT-6800052: FMIP (uniprotkb:Q13769) physically interacts (MI:0218) with THOC1 (uniprotkb:
Q96FV9) by anti tag coimmunoprecipitation (MI:0007)
MINT-6800022: THOC7 (uniprotkb:Q6I9Y2) physically interacts (MI:0218) with FMIP (uniprotkb:Q6DFL5)
by pull down (MI:0096)
MINT-6799989: THOC7 (uniprotkb:Q6I9Y2) binds (MI:0407) to FMIP (uniprotkb:Q13769) by pull down
(MI:0096)
MINT-6800071, MINT-6800089: FMIP (uniprotkb:Q13769) physically interacts (MI:0218) with THOC7
(uniprotkb:Q6I9Y2) and THOC1 (uniprotkb:Q96FV9) by anti tag coimmunoprecipitation (MI:0007)
Crown Copyright  2008 Published by Elsevier B.V. on behalf of the Federation of European
Biochemical Societies. All rights reserved.1. Introduction
THOC7 was originally identiﬁed as a binding partner of a puta-
tive transcriptional repressor, Ngg1 interacting factor like 1
(NIF3L1) [1]. THOC7 contains 204 amino acids with a putative leuc-
ince zipper (LZ). Although THOC7 does not contain a nuclear local-
ization signals (NLS) motif, THOC7 was detected in the nucleus and
cytoplasm [1]. Fms-interacting protein (FMIP) was originally iden-
tiﬁed as a binding partner and substrate for several tyrosine ki-
nases such as, Fms [2], Bcr-Abl, c-Kit (D816V), the Npm-Alk andd by Elsevier B.V. on behalf of the
(T. Tamura).Tel-PDGFb receptor [3]. FMIP has also been identiﬁed as a down-
stream signaling molecule by insulin stimulation in pre-adipocytes
[4] or by protein kinase C activation [5]. FMIP is a ubiquitous pro-
tein with a NLS, two LxxLL motifs, a putative PEST domain, and a
putative LZ and is a nucleocytoplasmic shuttling protein [5].
Both THOC7 and FMIP have been found to be members of the
THO complex, involved in mRNA processing [6,7]. The THO com-
plex was ﬁrst identiﬁed in Saccharomyces cerevisiae as a ﬁve-pro-
tein complex (THO2p, Hpr1p, Mft1p, Thp2p and Tex1p) [8–12]
that plays a role in transcriptional elongations, nuclear RNA export
and genome stability. In higher eukaryotes such as Drosophila mel-
anogaster [6] or the human [13] system, three proteins (THOC1/
hHpr1/p84, THOC2/hRlr1 and THOC3/fTex1) and three additional
unique proteins were identiﬁed, namely FMIP/THOC5/fSAP79,Federation of European Biochemical Societies. All rights reserved.
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THO complex. It has been suggested recently that the THO complex
binds to the 50 end of mRNA via cap binding protein 80 and Aly/
THOC4 [14]. However, by afﬁnity puriﬁcation using spliced human
mRNPs under physiological conditions, FMIP and THOC7 were co-
puriﬁed with Adenovirus pre-mRNA, but not with beta globin pre-
mRNA [15]. Interestingly, another member of THOC, THOC6, was
not detected in both cases. These data indicate that an individual
member of the THO complex seems to bind to only a certain pop-
ulation of pre-mRNA as well as that all members of the THO com-
plex may not function as a single subunit. Furthermore, it is not
clear that the direct interaction partners of the whole six
components in the complex. In this report we show that THOC7
interacts with FMIP but THOC6 does not. In addition, we have
mapped the interaction domain of THOC7 to FMIP and also
mapped the interaction domain of FMIP to THOC7. Finally, weFig. 1. FMIP forms a complex with THOC7. (A) Puriﬁed GST–THOC6, GST–THOC7 or GST
lysates. Bound protein was analyzed by SDS–PAGE followed by FMIP speciﬁc immunobl
brilliant blue (Coomassie blue staining). (B) 35S-methionine labelled in vitro transcribed
GST–THOC6 (). Bound materials were analyzed by SDS–PAGE. (C) Myc-tagged FMIP (My
HEK293 cells transiently and cell extracts obtained from nucleus (N) or cytoplasm were
FMIP or THOC1 speciﬁc immunoblot. (D) HEK293 cells were transfected with Myc-tagged
(the number represents the amino acid number). Bound materials were analyzed by M
staining with Coomassie brilliant blue (Coomassie staining). : GST and GST-fusion prot
with GST and GST–THOC7 and bound materials were analyzed by FMIP speciﬁc immunshow that interaction of THOC7 with FMIP is required for nuclear
localization of THOC7.
2. Materials and methods
2.1. Cell culture, plasmid construction and DNA transfection
HEK293, mouse embryo ﬁbroblasts (MEF) and HeLa cells were
grown in Dulbecco’s modiﬁed Eagle’s medium supplemented with
10% (v/v) FCS. Generation of green ﬂuorescent protein (GFP) and
Myc/His tagged FMIP was described previously [2,5]. BamHI–SalI
or BamHI–HindIII fragments obtained by PCR using THOC6 (IRAT-
p970A1277D, RZPD, Germany) and THOC7 (IRATp970D0486D) as
templates, were subcloned into pEGFP (Clontech Laboratories, CA,
USA), pcDNA3.1Myc His (Invitrogen, Carlsbad, CA, USA), or
pGEX5X-1 (Amersham Pharmacia Biotech Europe GmbH, Freiburg,(: 2 lg each) were bound to GT-sepharose beads and incubated with HEK293 cell
ot. As a control, aliquots were analyzed by SDS–PAGE and staining with Coomassie
/translated FMIP (wt) and FMIP (1–289) were incubated with GST, GST–THOC7 and
c-FMIP expressing cells) or THOC7 (Myc–THOC7 expressing cells) was expressed in
precipitated using anti THOC1 or anti-Myc antibody. Precipitates were analyzed by
FMIP and cell lysates were incubated with GST, GST wild-type and mutants THOC7
yc-speciﬁc immunoblot. As a control, aliquots were investigated by SDS–PAGE and
eins. LZ: putative leucin zipper domain. E: Xenopus oocyte extracts were incubated
oblot.
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agent as described by the manufacturer (Qiagen, Hilden, Germany).
2.2. Antibodies
Monoclonal antibody against FMIP (F6d) was described previ-
ously [16]. Monoclonal antibody against Myc (9E10) was from San-
ta Cruz Biotechnology (Santa Cruz, USA). TRITC or FITC labelled
anti-mouse or rabbit IgG were from Sigma–Aldrich GmbH. Mono-
clonal antibody against THOC1 (p84 N5) was from Gene Tex. Inc
(San Antonio, TX, USA).
2.3. In vitro transcription/translation
In vitro transcription/translation in the presence of 35S-methio-
nine was performed using the TNT quick coupled transcription/
translation system (Promega, Madison, USA) as described by the
manufacturer.
2.4. Cell extract preparation
For the glutathione-S-transferase (GST)-pulldown assay, cells
were extracted with lysis buffer containing 10 mM Tris–HCl, pH
7.6, 50 mM sodium ﬂuoride (NaF), 1 mM phenylmethylsulfonyl
ﬂuoride (PMSF), 10 mM EDTA, 1% Triton X-100, 1% Trasylol (BayerFig. 2. N-terminal domain of FMIP (1–199) binds to THOC7 directly. (A) Wild-type and
expressed in HEK293 cells transiently and cell extracts were incubated with GST or GST–
control, inputs were analyzed by SDS–PAGE and staining with Myc-speciﬁc immunoblot
PEST: PEST-like domain; LZ: a putative leucine zipper domain. (B) 35S-methionine labell
GST and GST–THOC7. Bound materials were analyzed by SDS–PAGE. (C) Myc-tagged FM
extracts were then precipitated by anti-Myc IgG, followed by Myc or THOC1 speciﬁc imVital, Leverkusen, Germany). For immunoprecipitation, the cyto-
plasmic fraction was prepared by buffer A (10 mM HEPES, pH
7.9, 1.4 mM MgCl2 10 mM KCl, 0.5 mM 1,4-dithiothreitol, 0.5 mM
PMSF, 0.5% NP40 and 1% Trasylol). After centrifugation, the nuclear
fraction was prepared with buffer A containing 375 mM KCl and
10% glycerol.
2.5. Western blot procedures
Details of immunoblotting have been described previously [17].
Results were documented on a LAS3000 imaging system (Fujiﬁlm,
Kanagawa, Japan).
2.6. GST-binding assay
Details of GST-binding assay have been described previously
[18]. Binding materials were analyzed by SDS–PAGE and autoradi-
ography or by immunoblotting.
2.7. Immunoﬂuorescence
Cells were washed with ice-cold PBS, ﬁxed in 3.7% formalde-
hyde in PBS for 20 min at room temperature, washed twice with
PBS and permeabilized using 0.1% Triton X-100 in 5% FCS PBS fordeletion mutants of FMIP (all numbers represent the amino acid numbers) were
THOC7 proteins. Bound materials were analyzed by Myc-speciﬁc immunoblot. As a
(10% of input). NLS: nuclear localization signal; WWB: WW domain binding motif;
ed in vitro transcribed/translated FMIP (wt) and FMIP (1–289) were incubated with
IP wt or its deletion mutants (1–559, 1–289) were expressed in HEK293 cells and
munoblotting.
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room temperature and stained using TRITC-anti-mouse IgG (Sig-
ma–Aldrich GmbH, München, Germany) for 30 min.
3. Results and discussion
3.1. FMIP forms a complex with directly THOC7, but not with THOC6
Since unique members of the metazoa THO complex, THOC7,
THOC6 and FMIP/THOC5 may not function as single subunit [15],
we examined the binding partner among these three proteins.
We ﬁrst generated GST–THOC7 (52 kDa) and GST–THOC6 fusion
proteins (63 kDa) (Fig. 1A, THOC7 antibodies are not available).
These puriﬁed GST-fusion proteins were then incubated with
HEK293 cell extract and bound proteins were ﬁrst analyzed by
FMIP/THOC5 speciﬁc immunoblot. GST–THOC7 precipitated
endogenous FMIP, however, GST–THOC6 failed to do so (Fig. 1A).Fig. 3. FMIP recruits THOC7 in the nucleus. (A) Hela cells were transfected with pEGFP p
pEGFP–THOC7 (THOC7) were co-transfected with pcDNA3 containing Myc-tagged FMIP. C
IgG (Myc staining). (C) GFP–THOC7 (1–204), GFP–THOC7 (1–137) and GFP–THOC7 (1–66
(1–204) with or without Myc-tagged FMIP were co-expressed in MEF and then treated
followed by TRITC-conjugated anti-mouse IgG (FMIP–Myc).To examine whether THOC7 and FMIP interact directly, we utilized
in vitro transcribed/translated FMIP for the GST–THOC7 and GST–
THOC6 pull down assay. FMIP binds to THOC7, but not to THOC6,
indicating that FMIP/THOC5 and THOC7 interact directly
(Fig. 1B). To conﬁrm that FMIP and THOC7 interact with each other
in vivo, we transfected Myc-tagged FMIP, or Myc-tagged THOC7
into HEK293 cells, then nuclear and cytoplasmic extracts were pre-
cipitated with Myc antibodies. As expected, FMIP precipitates con-
tain THOC1 (Fig. 1C, Myc–FMIP expressing cells), and THOC7
precipitates contain FMIP and THOC1 (Fig. 1C, Myc–THOC7
expressing cells). Furthermore, Myc-tagged THOC6 precipitates
did not contain either FMIP or THOC1 in this condition (data not
shown). We next mapped the binding domain of THOC7 to FMIP.
For this purpose, we generated GST-fusion proteins carrying the
second splice variant of THOC7 (1–137, all numbers represent
the amino acid number) which is found in public databases (Acces-
sion No. NM_001013578), or deletion mutants THOC7 (1–66) andlasmids containing FMIP, THOC6 and THOC7 cDNA. (B) pEGFP–THOC6 (THOC6) and
ells were stained with anti-Myc antibody followed by TRITC-conjugated anti-mouse
) were expressed in Hela cells with and without Myc-tagged FMIP. (D) GFP–THOC7
with (+) and without () TPA for 2 h. Cells were stained with anti-Myc antibody
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THOC7 (1–66) precipitated FMIP, suggesting that the FMIP binding
domain of THOC7 is located within the center portion of THOC7
(50–137). This domain exhibits a part of the putative LZ domain
(100–155, Fig. 1D) that may play a role in protein–protein interac-
tion or protein–DNA interaction. Furthermore, the binding domain
to FMIP differs from the NIF3L1 binding domain 1 (100–204) [1].
FMIP is conserved in all metazoa and Xenopus FMIP and THOC7
(public databases Accession Nos. NM_001087199, and
NM_001087182) have 80% and 89% amino acid identity with
human proteins, respectively. Since the mRNA export function of
human Aly/THOC4 was measured using Xenopus oocyte system
[14], we next examined whether Xenopus FMIP binds to GST–
human THOC7. As shown in Fig. 1E, Xenopus FMIP binds to GST–
THOC7. Furthermore, the monoclonal antibody raised against
human FMIP [16] recognized Xenopus FMIP protein.
3.2. The N-terminal domain of FMIP (1–199) binds to THOC7 directly,
while the C-terminal domain (559–683) is required for THOC1
association
We next examined the binding site of FMIP to THOC7. We
generated six deletion mutants of Myc-tagged FMIP (1–559, all
numbers represent the amino acid number), FMIP (1–499), FMIP
(1–409), FMIP (1–289), FMIP (1–199) and FMIP (1–100) (Fig. 2A).
FMIP (1–199) still binds to THOC7 but FMIP (1–100) does not, indi-
cating that the FMIP binding site of GST–THOC7 is located at the
N-terminal portion (1–199) (Fig. 2A). It is noteworthy that this
domain was identiﬁed previously as the binding site for Fms
tyrosine kinase (1–144) [2]. To conﬁrm whether THOC7 and the
N-terminal domain of FMIP interact directly, we utilized in vitro
transcribed/translated FMIP (wt) and FMIP (1–289) for the GST–
THOC7 pull down assay. Both FMIP (wt) and FMIP (1–289) bind
to THOC7 (Fig. 2B). To examine whether the binding domain for
THOC7 is different than the domain for THOC1, we once again
utilized the FMIP deletion mutant. Myc-tagged FMIP (wt), FMIP
(1–559) and FMIP (1–289) were expressed in HEK293 cells and cell
lysates were precipitated with Myc antibody. THOC1 was detected
only from precipitates with FMIP (wt), suggesting that the C-termi-
nal domain (559–683) that contains a putative LZ domain (620–
637) is required for THOC1 association with FMIP (Fig. 2C). The
expression of C-terminal truncated FMIP reduces the total amount
of THOC1 protein (Fig. 2C) and cells go into apoptosis (data not
shown). It is not clear at present how mutant FMIP destabilizes
THOC1. Interestingly, THOC1 is also nuclear–cytoplasm shuttling
protein with the death domain [19]. It has been shown that over-
expression as well as depletion of THOC1 cause apoptosis in
several cells [20]. We are currently investigating the molecular
mechanisms of the effect of FMIP mutants.
3.3. FMIP recruits THOC7 to the nucleus
It was shown that GFP–NIF3L1BP1/THOC7 fusion protein was
located in the cytoplasm as well as in the nucleus [1], while
we have shown previously that GFP–FMIP is mainly located in
the nucleus [5]. Since THOC7 does not contain a typical NLS mo-
tif, we examined the nuclear import of THOC7. We ﬁrst studied
the subcellular localization of THOC7. As a negative control, we
also examined GFP–THOC6 that does not bind to FMIP. In agree-
ment with previous data, GFP–THOC7 is detected in the cyto-
plasm as well as in the nucleus, while GFP–FMIP is found
exclusively in the nucleus (Fig. 3A). GFP–THOC6 was detected
in the cytoplasm. Since the overexpression of THOC7 may cause
impairment of stoichiometry of endogenous proteins, we next
co-expressed GFP–THOC7 with Myc-tagged FMIP, all of which
are directed by CMV promoter. To examine whether FMIP inﬂu-ences the subcellular distribution of THOC7, we co-expressed
GFP–THOC7 with Myc-tagged FMIP. Interestingly, THOC7, but
not THOC6 was detected mainly in the nucleus when FMIP was
co-expressed (Fig. 3B), suggesting that THOC7 is imported into
the nucleus together with FMIP. To conﬁrm that the binding site
of THOC7 to FMIP is important for co-localization, we co-trans-
fected GFP–THOC7 (1–204), GFP–THOC7 (1–137) and GFP–THOC7
(1–66) with Myc-tagged FMIP. GFP–THOC7 (1–204) and (1–137)
were detected mainly in the nucleus with FMIP, however, the
location of THOC7 (1–66) did not change (Fig. 3C). We have
shown previously that activation of protein kinase C (PKC) alpha
induces the cytoplasmic translocation of FMIP [5]. Therefore, we
next examined whether THOC7 is also translocated with FMIP
upon stimulation with TPA, an activator of PKC-a. As shown in
Fig. 3D, THOC7 was translocated with FMIP into the cytoplasm
within 2 h, indicating that phosphorylation states of FMIP inﬂu-
ence subcellular localization of THOC7. Furthermore, by afﬁnity
puriﬁcation using spliced human mRNPs under physiological
conditions, endogenous FMIP with endogenous THOC7 were co-
puriﬁed in all cases, but not with THOC1, THOC2 and THOC6
[15], suggesting that the FMIP and THOC7 complex may act as
one functional unit.
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